Subclavian Artery Chronic Total Occlusion (CTO) Recanalization Using the Truepath Device  by Madassery, S. et al.
EJVES Short Reports (2015) 29, 8e10TECHNICAL NOTESubclavian Artery Chronic Total Occlusion (CTO) Recanalization Using the
Truepath Device
S. Madassery, T. Souman, B. Arslan, U.C. Turba *
Rush University Medical Center, Interventional Radiology, Chicago, IL, USA* Co
Buildin
E-ma
2405
Europe
CC BY-
httpKeywords: Subclavian steal syndrome, Chronic total occlusionINTRODUCTION
A 57 year old woman presented with dizziness and vertigo,
and on physical examination was found to have asymmetric
blood pressure in the upper extremities (80/50 mmHg on
the left versus 150/80 mmHg on the right), as well as a
decreased left radial pulse. She had a history of left lower
extremity weakness, residual from a cerebrovascular acci-
dent in 2009. She was referred to interventional radiology
(IR), after transfer from an outside hospital with left sub-
clavian artery occlusion, noted on a CT angiogram of the
chest. Before presentation at the study institution, surgical
treatment had been offered; however, the patient refused
open surgical treatment and instead opted for non-surgical
or endovascular treatment, if available.
SURGICAL TECHNIQUE
This is a single case, therefore exempt from the study
institutional board review. Aortic arch arteriography was
performed with a 120 cm, 5 Fr sizing Pigtail catheter (Cook
Medical, Bloomington, IN), which showed occlusion of the
left subclavian artery with a minute stump. Delayed phase
arteriography demonstrated retrograde opaciﬁcation of the
left subclavian artery about 2 cm distal to its origin, via the
left vertebral artery and collaterals from the external ca-
rotid and maxillary arteries (Fig. 1A). Next, a 5 Fr Pinnacle
(Terumo, Somerset, NJ) sheath was placed in the left
brachial artery under ultrasound guidance, and heparin
(5000 units) was administered. A Bentson wire (Cook
Medical, Bloomington, IN) was advanced to the left axillary
artery. Then a 65 cm, 4 Fr angled Glidecath (Terumo,
Somerset, NJ) was advanced to the left subclavian artery to
traverse the total occlusion with a hydrophilic guidewire
such as Glidewire (Terumo, Somerset, NJ). Contrast injec-
tion into the subclavian artery demonstrated ﬂow reversal
in the left vertebral artery, with ﬂow directed towards the
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this time, it was decided to place a 4 mm Spider (EV3
Endovascular, Plymouth MN) distal protection device, which
was advanced into the mid left vertebral artery. Then a
0.035 inch Glidewire (Terumo, Somerset, NJ) was used to
perform recanalization through the subclavian artery into
the arch from the aorta; however, this was unsuccessful
because of the shallow stump, a near ﬂush occlusion at the
aortic arch. Then multiple recanalization attempts via sub-
clavian artery also failed, with use of Glidewires (Terumo,
Somerset, NJ) including regular and stiff forms, which
created subintimal tracts without re-entry to the aorta. At
this point the options were either aborting the procedure or
using a low proﬁle CTO crosser which was not designed for
this application. Next, a 135 cm length, 2.5 Fr Cantata (Cook
Medical, Bloomington, IN) microcatheter was advanced
coaxially through the macrocatheter. Then, triaxially, a
165 cm length, 0.018 inch TruePath CTO device (Boston
Scientiﬁc, Marlborough, MA) successfully recanalized an
intraluminal path from the occluded left subclavian artery,
through the arch, and into the proximal descending aorta
(Fig. 1B). Next the microcatheter was advanced over the
True Path CTO device and followed by a Glidecath (Terumo,
Somerset, NJ).
Through the common femoral arterial access, a 6 Fr, 70 cm
Flexor Ansel sheath (Cook Medical, Bloomington, IN) was
advanced into the descending thoracic aorta. A 5 Fr Amplatz
Gooseneck snare device (EV3 Endovascular, Plymouth, MN)
was used to gain “ﬂossing access” (Fig. 1C) and exchanged
with an Amplatz guidewire (Boston Scientiﬁc, Marlborough,
MA) for intervention. Then a 6 mm  22 mm ICAST (Atrium,
Hudson, NH) covered balloon expandable stent was
advanced and deployed across the occlusion of the proximal
left subclavian artery. Completion arteriogram from the
aortic arch demonstrated wide patency of the recanalized
subclavian artery with near complete resolution of collat-
eralized ﬂow (Fig. 1D). The embolization protection device
was removed and evaluated, demonstrating a few small
fragments of tissue. Immediate neurologic examination was
unremarkable. The recovery period was uneventful and the
patient was discharged 3 days after the transfer from the
prior hospital with a prescription of clopidogrel. At follow up
(3 months) the patient reported marked improvement of
presenting symptoms of vertigo and dizziness.
Figure 1. (A) Three dimensional CT reconstruction shows occlusion of the subclavian artery. (B) Initial evaluation thoracic aortic arch
arteriogram demonstrating segment of occluded proximal left subclavian artery, with collateral ﬂow to the more peripheral subclavian
artery. The total occlusion length was 2.2 cm. The left vertebral artery origin was approximately 7 mm from the point of occlusion. (C)
Simultaneous Truepath CTO device recanalizing the occluded segment of left subclavian artery, with snare device awaiting capture from
the groin. (D) Successful capturing of the microglidewire passed through the recanalized subclavian artery. (E) After stenting of the left
subclavian artery demonstrates appropriate antegrade ﬂow, with lack of signiﬁcant collateral ﬂow.
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Protecting the vertebral circulation during recanalization
attempts is of great importance, as evidenced by the small
tissue fragments retrieved from the protection device after
removal.1 There is a considerable lack of literature
describing the use of CTO devices for chronic occlusions in
the arch vessels. The present case is reported as an unusual
technique utilizing a low proﬁle CTO device in a patient
presenting with subclavian steal syndrome and unsuccessful
recanalization using conventional methods. Typically, most
recanalizations are achieved with hydrophilic guidewires,
which are primarily successful in subtotal occlusions.2,3
However, there is well known signiﬁcant difﬁculty and fail-
ures when encountering chronic total occlusions, mostly
because of calciﬁed caps at the ends of the CTO.4 Other
techniques employed for CTO crossing include controlled
blunt micro-dissection, and optical coherence reﬂectometry
guided RFA guidewires, again, however, not designed forthis application.5 Even though it is an off label application,
there is a need for a lower proﬁle CTO crosser device for
larger vessels, and larger CTO crosser devices are not
commonly used in these vessels because of a fear of po-
tential complications such as arch aortic dissection.CONCLUSION
In the present case, the Truepath device allowed comple-
tion of a procedure with technical success and without
complications; however, it should be noted that this is an
off label application of this device. Low proﬁle CTO devices
may be potentially beneﬁcial in the greater arch vessels and
in patients who are not good surgical candidates, or those
patients refusing surgical treatment.CONFLICT OF INTEREST
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